What is NGEN's relative strength rating?

NGEN ranks at the 87th percentile over 1 month, 40th percentile over 3 months, 8th percentile over 6 months against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is NGEN in?

NGEN is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is NGEN in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). NGEN benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is NGEN?

NGEN currently shows a 20-day average daily range (ADR%) of 5.2%, a 90-day beta versus the S&P 500 of 1.11. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does NGEN have a seasonal pattern?

TickerStance computes NGEN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NGEN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did NGEN last report earnings?

No SEC EDGAR filings are linked to NGEN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Free

NGEN · RS 40

Power rating ↑RS percentile →

One point among 5,323 · As of Monday, August 24, 2026, posted ~17:00 ET

NGEN

NGEN is not confirmed as a leader. 40 is not yet a leadership-grade RS read, Market Stance is 47.8

NervGen Pharma Corp. Common stock (NGEN) — Stance & relative strength

Healthcare · Pharmaceutical Products

$2.00▲ +7.53% todayUSD · close

▼ Stance 48 · Neutral

NGEN$2.00▲ +7.53%

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, NervGen Pharma Corp. Common stock (NGEN) has a 3-month relative strength percentile of 40 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 2.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month40pctile

6 month8pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile 24

✓ADR%5.2%✓A/DB✓RVOL2.88×!$ Vol$1M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

Not enough history to compute monthly seasonality for NGEN.

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

BAccum

RVOL todayvs 50d avg

2.88×

U/D ratiolast 50 sessions

1.12

Breakout volbreakout day vs 50d avg

+65%

50d avg $ volumeliquidity proxy

$1.2M

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

5.2%Elevated

ATR(14)14-day EMA

$0.11

ATR%ATR as % of close

5.33%

Beta vs SPY90d rolling

1.11

1-ADR stoprisk from close $2.00

$1.90−5.2%

Fundamentals · NGEN

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
NGEN
40RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

EBSEmergent Biosolutions, Inc.8 TVRDTvardi Therapeutics, Inc. Common Stock8 DAREDare Bioscience, Inc. Common Stock8 BTAIBioXcel Therapeutics, Inc. Common Stock8

Public attention · NGEN

Is the crowd watching?

53/ 100 · vs its own 90-day norm▲ 13 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float63.9Mshares

Shares out107.5Mshares

Market cap$215.0MMicro Cap

FAQ

Frequently asked questions

What is NGEN's relative strength rating?: NGEN ranks at the 87th percentile over 1 month, 40th percentile over 3 months, 8th percentile over 6 months against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is NGEN in?: NGEN is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is NGEN in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). NGEN benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is NGEN?: NGEN currently shows a 20-day average daily range (ADR%) of 5.2%, a 90-day beta versus the S&P 500 of 1.11. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does NGEN have a seasonal pattern?: TickerStance computes NGEN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NGEN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did NGEN last report earnings?: No SEC EDGAR filings are linked to NGEN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Loading ticker…

NervGen Pharma Corp. Common stock (NGEN) — Stance & relative strength

NGEN is not confirmed as a leader. 40 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

NervGen Pharma Corp. Common stock (NGEN) — Stance & relative strength

NGEN is not confirmed as a leader. 40 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions